Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-022859
Filing Date
2026-07-07
Accepted
2026-07-07 06:01:10
Documents
3
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K athe20260707_6k.htm 6-K 10999
2 EXHIBIT 99.1 ex_985272.htm EX-99.1 20437
3 logo.jpg GRAPHIC 6803
  Complete submission text file 0001437749-26-022859.txt   42116
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 261157759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)